Glass House Brands retained former DEA compliance executive Matt Murphy to advise on Schedule III CSA requirements tied to potential interstate commerce.
The mandate includes compliance frameworks for possible exports of medical cannabis under DEA-enforced CSA and CFR rules.
The move positions the company for regulatory change that could open higher-priced out-of-state U.S. markets or Europe, subject to federal rules.
GLAS•
